STAT notes RFK Jr. and the MAHA movement have embraced peptides, though evidence for many of these wellness compounds is thin. A July FDA panel backed all six.
Recap by typeshit. Full story at STAT.
STAT
The temporary enforcement discretion covers six peptides an FDA advisory committee recommended in July. STAT notes there is little evidence for many of these wellness compounds.
A US judge turned down Novo's request to halt Lilly's Zepbound advertising while the false advertising dispute continues.
STAT
STAT's Pharmalittle notes Catherine Hanaway says Lilly broke its promise on discounted drugs to hospitals, alongside new results for a Lilly weight loss drug.
AP reports agency scientists did not back the administration's effort to loosen rules on peptide drugs that remain unproven.
STAT
Top-dose patients cut A1c by 2.2 points and lost 20.9% of body weight, versus 1.8 points and 9.4% on Ozempic, per Lilly's on-treatment analysis.
Investor's Business Daily reports Hims shares rose Wednesday after RFK Jr. went around the FDA to allow certain unapproved peptides.
Loading…